BIOMAT Database Logo BIOMAT Database Logo

Letter: ICRF 159. 1974

A M Creighton

UI MeSH Term Description Entries
D009374 Neoplasms, Experimental Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms. Experimental Neoplasms,Experimental Neoplasm,Neoplasm, Experimental
D010879 Piperazines Compounds that are derived from PIPERAZINE.
D011407 Propane A three carbon alkane with the formula H3CCH2CH3.
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy

Related Publications

A M Creighton
Letter: ICRF 159.
May 1974, Lancet (London, England),
A M Creighton
Editoral: ICRF 159.
March 1974, Lancet (London, England),
A M Creighton
[ICRF 159--a cytostatic substance].
October 1978, Deutsche medizinische Wochenschrift (1946),
A M Creighton
Razoxane (ICRF 159) in psoriasis.
December 1976, Lancet (London, England),
A M Creighton
Cumulative cytostatic effect of ICRF 159.
February 1974, Nature,
A M Creighton
in vitro effects of ICRF 159.
July 1973, British journal of cancer,
A M Creighton
ICRF-159: current status and clinical prospects.
November 1977, European journal of cancer,
A M Creighton
Bioassay of ICRF-159 for possible carcinogenicity.
January 1978, National Cancer Institute carcinogenesis technical report series,
A M Creighton
Effect of ICRF 159 on immune responses.
March 1972, Proceedings of the Royal Society of Medicine,
A M Creighton
Blood clearance of ICRF 159 (NSC-129943).
December 1971, Cancer chemotherapy reports,
Copied contents to your clipboard!